Figure 1
From: MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
Chemical structures of compounds used. 17beta-estradiol (E2), 4-hydroxytamoxifen (OHT), G-1 and ethyl 3-[5-(2-ethoxycarbonyl-1-methylvinyloxy)-1-methyl-1H-indol-3-yl]but-2-enoate (MIBE).